Breast and Cervical Cancer Press Releases
A new report released by the American Cancer Society (ACS) last month revealed a shift in the burden of the disease from men to women. Cases of cancer are declining in men while diagnoses are rising in women, specifically younger women. A continued drop in cancer mortality was also noted in the report, thanks in part to advances in early detection and treatment of cancer. The report coincides with the beginning of the 2025 legislative session and the recent introduction of House Bill 433. Supporters of Representative Gina Curry’s legislative proposal include the nonprofit, nonpartisan advocacy affiliate of ACS, the American Cancer Society Cancer Action Network (ACS CAN), and Susan G. Komen For the Cure. One ACS CAN volunteer, a local Pittsburgh breast cancer survivor, is sounding the alarm on the recent report and urging state lawmakers to see House Bill 433 as an opportunity to address the troubling trend.
Volunteer advocates from across Arizona, including cancer survivors, patients and caregivers, rallied at the state Capitol on Thursday for ‘Cancer Action Day,’ an event hosted annually by the the American Cancer Society Cancer Action Network (ACS CAN). Advocates met with lawmakers and urged them to support policies that increase access to quality health care and prevent tobacco use.
BISMARCK, N.D. -- The North Dakota House Business, Industry and Labor Committee on Wednesday gave a “do pass recommendation” on legislation that, if successfully passed, will lead to better outcomes in the fight against breast cancer.
Governor Josh Shapiro presented his state budget to the legislature yesterday, outlining his vision for the coming fiscal year. In his budget address, Governor Shapiro proposed to maintain funding for key cancer prevention and detection programs and acknowledged health care costs and price transparency as a continued area of interest, which secured high praise from patient advocates concerned over the role cancer plays in limiting Pennsylvanians’ financial mobility. Advocates are hopeful that the budget negotiation process yields progress on additional health care affordability issues, including Pennsylvanians’ access to paid leave, medical debt relief and lifesaving medications.
PIERRE, S.D. – The South Dakota House Commerce and Energy Committee today missed a significant opportunity to make progress against breast cancer, voting to fail legislation on supplemental screenings.
PIERRE, S.D. –– American Cancer Society Cancer Action Network (ACS CAN) advocates will arrive at the Statehouse Wednesday for their annual Day at the Capitol.
LAS VEGAS, NEV. – The High Roller Observation Wheel at The Linq Promenade shined teal and white on Friday night in honor of Cervical Cancer Awareness Month, which is observed in January. The American Cancer Society Cancer Action Network (ACS CAN) joined other local advocacy groups and cervical cancer survivors at The Linq Promenade to recognize those who have battled the disease.
The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) New York Senior Government Relations Director Michael Davoli:
“Coming off Governor Hochul’s State of the State address earlier this week, where access to and the costs of health care were sparingly mentioned, patient advocates are hopeful that the governor prioritizes health care affordability in her executive budget proposal for FY 2025-26.
TALLAHASSEE, Florida – As Florida legislators begin committee meetings for the 2025 session, the American Cancer Society Cancer Action Network (ACS CAN) calls on them to prioritize reducing the cancer burden on Floridians.
As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.
